Your selection
Innovation / 28.07.2025
Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) resolved on June 18, 2025, to increase the share capital using company funds by € 42,343,864 to € 63,515,796.
The capital increase was entered in the commercial register on 25 July 2025 and thus became effective. As a result, the company's share capital increased from € 21,171,932 to € 63,515,796.
The company will report on the exact details of the share split once the technical details have been finalized with the banks.
The share split aims in particular to increase the liquidity of the share and thus facilitate the tradability of Eckert & Ziegler shares.
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Source: Press Release Eckert & Ziegler
Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation
Overview News
News Buch Berlin
Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased sales in the first nine months of 2025 by 4% to €224.1 million compared to the same period last year. EBIT before special items from continuin...
more ...T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy
Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing. TK-6302 Clinical Trial Application planned in Q4 20...
more ...Why APOE4 raises Alzheimer’s risk
Researchers at the Max Delbrück Center and Aarhus University have found a mechanism through which the gene variant APOE4, long linked to a high risk of developing Alzheimer’s disease, impairs neuronal...
more ...Events Buch Berlin
16.12.2025, 15:30
Weihnachtliche Führung durch die einzigartige Sammlung historischer Mikroskope auf dem Campus Berlin-Buch
Lernen Sie die Anfänge der Berliner Mikroskop-Produktion und ihren Einfluss auf die moderne Biomedizin kennen - unter anderem auf die medizinische Forschung in Berlin-Buch!
more ...16.12.2025, 16:30
Invitation: Christmas tour of the unique collection of historical microscopes on the Campus Berlin-Buch
Discover the beginnings of Berlin’s microscope production and its influence on modern biomedicine. Neuroscientist Prof. Dr. Helmut Kettenmann will guide you through the microscope exhibition at the Ma...
more ...06.01.2026, 16:00
Vorlesung und Lehrerfortbildung: "Wenn das Immunsystem das Gehirn angreift – Autoimmunerkrankungen des zentralen Nervensystems"
Vorlesungsreihe: Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch. Für Lehrkräfte, Schülerinnen und Schüler sowie Interessierte.
more ...
